Literature DB >> 18038207

Presence and characterization of the dopamine transporter in human resting lymphocytes.

Donatella Marazziti1, Stefano Baroni, Mario Catena Dell'Osso, Irene Masala, Laura Fabbrini, Laura Betti, Gino Giannaccini, Bernardo Dell'osso, Antonio Lucacchini.   

Abstract

The paucity of information on the presence of the dopamine transporter (DAT) in blood cells, prompted us to explore it in human resting lymphocytes by means of the binding of 3H-WIN 35,428, a compound which is currently considered the most selective ligand for labelling this protein, and by means of the specific reuptake of 3H-dopamine (3H-DA). Lymphocytes were obtained by 15 healthy subjects. The results showed the presence of a specific and saturable binding of 3H-WIN 35,428, which labelled one site only. A specific 3H-DA reuptake was also measured. The pharmacological characterization of both binding and reuptake was overlapping. These findings would indicate that human resting lymphocytes carry the DAT, whose functions in periphery are still unknown.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038207     DOI: 10.1007/s11064-007-9541-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.

Authors:  J W Boja; F I Carroll; R A Vaughan; T Kopajtic; M J Kuhar
Journal:  Synapse       Date:  1998-09       Impact factor: 2.562

2.  Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease.

Authors:  B Caronti; G Tanda; C Colosimo; S Ruggieri; C Calderaro; G Palladini; F E Pontieri; G Di Chiara
Journal:  Neuroreport       Date:  1999-09-29       Impact factor: 1.837

3.  Immunocytochemical localization of the dopamine transporter in human brain.

Authors:  B J Ciliax; G W Drash; J K Staley; S Haber; C J Mobley; G W Miller; E J Mufson; D C Mash; A I Levey
Journal:  J Comp Neurol       Date:  1999-06-21       Impact factor: 3.215

4.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

5.  Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.

Authors:  Okechukwu T Ukairo; Corry D Bondi; Amy Hauck Newman; Santosh S Kulkarni; Alan P Kozikowski; Stephen Pan; Christopher K Surratt
Journal:  J Pharmacol Exp Ther       Date:  2005-05-05       Impact factor: 4.030

6.  A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients.

Authors:  A Rotman; H Munitz; I Modai; S Tjano; H Wijsenbeek
Journal:  Psychiatry Res       Date:  1980-12       Impact factor: 3.222

7.  Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.

Authors:  Z B Pristupa; F McConkey; F Liu; H Y Man; F J Lee; Y T Wang; H B Niznik
Journal:  Synapse       Date:  1998-09       Impact factor: 2.562

8.  Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth.

Authors:  C W Tsao; Y S Lin; J T Cheng
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

9.  Dopamine uptake in platelets: two different low-affinity, saturable mechanisms.

Authors:  O Lingjaerde; O Kildemo
Journal:  Agents Actions       Date:  1981-07

10.  Identification of catecholamines in the immune system by electrospray ionization mass spectrometry.

Authors:  J Bergquist; J Silberring
Journal:  Rapid Commun Mass Spectrom       Date:  1998       Impact factor: 2.419

View more
  7 in total

Review 1.  Neuroimmune Communication in Health and Disease.

Authors:  Colin Reardon; Kaitlin Murray; Alan E Lomax
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 2.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

3.  Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy.

Authors:  Francesca R Buttarelli; Annapia Circella; Clelia Pellicano; Dorina Tiple; Morena Giovannelli; Carlo Colosimo; Francesco E Pontieri
Journal:  J Neural Transm (Vienna)       Date:  2008-12-17       Impact factor: 3.575

4.  The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

Authors:  Francesca R Buttarelli; Alessandra Fanciulli; Clelia Pellicano; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 5.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

6.  Human Immunodeficiency Virus (HIV) Infection and Use of Illicit Substances Promote Secretion of Semen Exosomes that Enhance Monocyte Adhesion and Induce Actin Reorganization and Chemotactic Migration.

Authors:  Yuan Lyu; Hussein Kaddour; Steven Kopcho; Tyler D Panzner; Nadia Shouman; Eun-Young Kim; Jeremy Martinson; Heather McKay; Otoniel Martinez-Maza; Joseph B Margolick; Jack T Stapleton; Chioma M Okeoma
Journal:  Cells       Date:  2019-09-03       Impact factor: 7.666

7.  Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse.

Authors:  Peter J Gaskill; Loreto Carvallo; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroinflammation       Date:  2012-08-18       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.